S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
The Collapse of 2022 Has Begun (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
The Collapse of 2022 Has Begun (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
The Collapse of 2022 Has Begun (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
The Collapse of 2022 Has Begun (Ad)pixel
NASDAQ:ESTA

Establishment Labs - ESTA Stock Forecast, Price & News

$65.40
+1.27 (+1.98%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$63.07
$65.51
50-Day Range
$51.03
$66.79
52-Week Range
$46.93
$93.80
Volume
110,221 shs
Average Volume
157,035 shs
Market Capitalization
$1.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$99.00

Establishment Labs MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
51.4% Upside
$99.00 Price Target
Short Interest
Bearish
8.64% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.65mentions of Establishment Labs in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.20) to ($1.41) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.81 out of 5 stars

Medical Sector

775th out of 1,135 stocks

Surgical Appliances & Supplies Industry

17th out of 23 stocks

ESTA stock logo

About Establishment Labs (NASDAQ:ESTA) Stock

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Analysts Set New Price Targets

A number of research firms recently commented on ESTA. Cowen increased their target price on shares of Establishment Labs from $95.00 to $125.00 in a research report on Friday, April 22nd. The Goldman Sachs Group increased their target price on shares of Establishment Labs from $57.00 to $65.00 and gave the company a "neutral" rating in a research report on Tuesday, August 9th. Cowen increased their target price on shares of Establishment Labs from $95.00 to $125.00 in a research report on Friday, April 22nd. Finally, BTIG Research decreased their target price on shares of Establishment Labs from $105.00 to $90.00 and set a "buy" rating for the company in a research report on Friday, June 24th.

Establishment Labs Price Performance

Establishment Labs stock traded up $1.27 during mid-day trading on Friday, reaching $65.40. 110,221 shares of the company traded hands, compared to its average volume of 157,035. The company has a current ratio of 4.50, a quick ratio of 2.23 and a debt-to-equity ratio of 9.17. Establishment Labs has a fifty-two week low of $46.93 and a fifty-two week high of $93.80. The firm's fifty day moving average is $57.70 and its two-hundred day moving average is $60.42.

Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

ESTA Stock News Headlines

Establishment Labs (NASDAQ:ESTA) Trading Down 3.1%
Recap: Establishment Labs Hldgs Q4 Earnings
See More Headlines
Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

ESTA Company Calendar

Last Earnings
11/09/2021
Today
8/14/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ESTA
Fax
N/A
Employees
746
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$99.00
High Stock Price Forecast
$125.00
Low Stock Price Forecast
$65.00
Forecasted Upside/Downside
+51.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-41,140,000.00
Pretax Margin
-48.68%

Debt

Sales & Book Value

Annual Sales
$126.68 million
Book Value
$0.66 per share

Miscellaneous

Free Float
21,200,000
Market Cap
$1.58 billion
Optionable
Not Optionable
Beta
1.11

Key Executives

  • Mr. Juan Jose Chacon Quiros (Age 50)
    Founder, CEO & Exec. Director
    Comp: $841.32k
  • Mr. Rajbir Singh Denhoy (Age 52)
    Chief Financial Officer
    Comp: $421.42k
  • Mr. Pratip Dastidar (Age 59)
    Head of Global Operations
    Comp: $424.49k
  • Mr. Roberto de Mezerville (Age 41)
    Chief Technology Officer
  • Ms. Neeta Toprani
    Gen. Counsel & Corp. Sec.
  • Mr. Jeffrey Clark Bettinger
    Global Head of People
  • Mr. Salvador Santos Dada (Age 39)
    Chief Operating Officer (Medical Leave of Absence)
  • Dr. Heather Brennan
    Head of U.S. Commercial Operations













ESTA Stock - Frequently Asked Questions

Should I buy or sell Establishment Labs stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ESTA shares.
View ESTA analyst ratings
or view top-rated stocks.

What is Establishment Labs' stock price forecast for 2022?

3 brokers have issued 1 year price targets for Establishment Labs' shares. Their ESTA share price forecasts range from $65.00 to $125.00. On average, they expect the company's share price to reach $99.00 in the next year. This suggests a possible upside of 51.4% from the stock's current price.
View analysts price targets for ESTA
or view top-rated stocks among Wall Street analysts.

How have ESTA shares performed in 2022?

Establishment Labs' stock was trading at $67.59 at the start of the year. Since then, ESTA stock has decreased by 3.2% and is now trading at $65.40.
View the best growth stocks for 2022 here
.

When is Establishment Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our ESTA earnings forecast
.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by $0.27. The business earned $29.04 million during the quarter, compared to the consensus estimate of $27.50 million. Establishment Labs had a negative trailing twelve-month return on equity of 129.28% and a negative net margin of 49.94%. During the same period last year, the business posted ($0.18) earnings per share.

What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs issued an update on its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $155.00 million-$165.00 million, compared to the consensus revenue estimate of $161.73 million.

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Conduent (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

When did Establishment Labs IPO?

(ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

What is Establishment Labs' stock symbol?

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Who are Establishment Labs' major shareholders?

Establishment Labs' stock is owned by many different retail and institutional investors. Top institutional investors include Brown Advisory Inc. (6.77%), Cowen AND Company LLC (3.46%), Artisan Partners Limited Partnership (1.20%), Kornitzer Capital Management Inc. KS (1.16%), Assenagon Asset Management S.A. (0.66%) and Affinity Asset Advisors LLC (0.00%). Insiders that own company stock include Dennis E Condon, Dennis E Condon, Edward J Schutter, Jw Asset Management, Llc, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Renee Gaeta and Santos Salvador Dada.
View institutional ownership trends
.

How do I buy shares of Establishment Labs?

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Establishment Labs' stock price today?

One share of ESTA stock can currently be purchased for approximately $65.40.

How much money does Establishment Labs make?

Establishment Labs (NASDAQ:ESTA) has a market capitalization of $1.58 billion and generates $126.68 million in revenue each year. The company earns $-41,140,000.00 in net income (profit) each year or ($2.96) on an earnings per share basis.

How many employees does Establishment Labs have?

The company employs 746 workers across the globe.

How can I contact Establishment Labs?

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The official website for the company is www.establishmentlabs.com. The company can be reached via phone at (062) 434-2400 or via email at ir@establishmentlabs.com.

This page (NASDAQ:ESTA) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.